ArticleScientific reports2026
Quantum denoising autoencoder improves retinal fundus image quality for early diabetic retinopathy screening.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetic Retinopathy (DR) is a critical source of blindness that can be prevented globally, and accurate analysis of retinal fundus images enables early detection. Fundus images are often affected by multiple noise sources, which impair image quality and hinder the observation of delicate retinal structures, including microaneurysms and small blood vessels. Deep learning driven denoising models are computationally intensive and prone to overfitting on small medical datasets. In order to overcome these shortcomings, the present paper suggests a Quantum Denoising Autoencoder (QDAE), a hybrid quantum-classical architecture, which uses convolutional feature coding with parameterized quantum circuits (PQCs) in latent space. The suggested QDAE applies quantum superposition and entanglement to improve the latent representations, thereby improving denoising and retinal detail preservation. Experiments on the Diabetic Retinopathy 224 × 224 (2019) dataset show that QDAE performs considerably better than classical denoising architectures, including CAE, ResNet, and DnCNN with PSNR of 38.8 dB, SSIM of 0.96, and AMI of 0.88. The approach preserves delicate retinal patterns and intensity consistency, while incurring a slight computational overhead associated with shallow quantum circuits. The results presented above demonstrate that QDAE is a potential quantum-aided architecture for denoising retinal images and a feasible preprocessing procedure in early diabetic retinopathy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.